Cover Image
Market Research Report

North America Cell-based Assays Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 913489
Published Content info 80 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Cell-based Assays Market: Industry Trends and Forecast to 2026
Published: October 1, 2019 Content info: 80 Pages
Description

North America cell based assays market is projected to register a substantial CAGR in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Others), Product & Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening, Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect), Country (U.S., Canada, Mexico)

Some of the major factors contributing to the growth of the market:

  • Rising demands for cell based therapies
  • Increasing life sciences R&D expenditure in cell based assays area in North America
  • Increasing incidence of chronic diseases like cancer

Key Market Players:

The key market players for North America cell based assays market are listed below:

  • GENERAL ELECTRIC
  • Danaher
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • ATCC
  • Aurelia Bioscience Ltd
  • BD
  • BioAgilytix Labs
  • BioVision Inc.
  • Cell Signaling Technology, Inc
  • Cisbio
  • Enzo Biochem Inc
  • Eurofins Scientific
  • LakePharma, Inc
  • Lonza
  • Miltenyi Biotec
  • XenoDiagnostics, LLC
Table of Contents

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. OVERVIEW OF NORTH AMERICA CELL BASED ASSAYS MARKET
  • 1.4. LIMITATIONS
  • 1.5. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. MARKETS COVERED
  • 2.2. NORTH AMERICA CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE
  • 2.3. YEARS CONSIDERED FOR THE STUDY
  • 2.4. CURRENCY AND PRICING
  • 2.5. DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7. DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS)
  • 2.8. DBMR MARKET POSITION GRID
  • 2.9. DBMR VENDOR SHARE ANALYSIS
  • 2.10. MULTIVARIATE MODELING
  • 2.11. PRODUCTS LIFELINE CURVE
  • 2.12. SECONDARY SOURCES
  • 2.13. ASSUMPTIONS

3. MARKET OVERVIEW

  • 3.1. DRIVERS
    • 3.1.1. INCREASING INCIDENCE OF CHRONIC DISEASES
    • 3.1.2. RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES
    • 3.1.3. INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE
  • 3.2. RESTRAINT
    • 3.2.1. STRINGENT REGULATORY REQUIREMENTS
    • 3.2.2. HIGH COST OF INSTRUMENTATION
  • 3.3. OPPORTUNITIES
    • 3.3.1. TECHNOLOGICAL ADVANCEMENTS
    • 3.3.2. STRATEGIC INITIATIVE BY THE MARKET PLAYERS
  • 3.4. CHALLENGES
    • 3.4.1. CHALLENGING ANALYSIS PROCEDURE

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. NORTH AMERICA CELL-BASED ASSAYS MARKET, BY TYPE

  • 6.1. OVERVIEW
  • 6.2. CELL VIABILITY ASSAY
  • 6.3. CYTOTOXICITY ASSAY
  • 6.4. CELL PROLIFERATION ASSAY
  • 6.5. CELL DEATH ASSAY
  • 6.6. OTHERS

7. NORTH AMERICA CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES

  • 7.1. OVERVIEW
  • 7.2. CONSUMABLES
    • 7.2.1. ASSAY KITS
    • 7.2.2. CELL LINES
      • 7.2.2.1. PRIMARY CELL LINES
      • 7.2.2.2. STEM CELL LINES
      • 7.2.2.3. IMMORTALIZED CELL LINES
    • 7.2.3. REAGENTS
    • 7.2.4. MICROPLATES
  • 7.3. SERVICES
  • 7.4. INSTRUMENTS AND SOFTWARE

8. NORTH AMERICA CELL-BASED ASSAYS MARKET, BY TECHNOLOGY

  • 8.1. OVERVIEW
  • 8.2. HIGH THROUGHPUT SCREENING
  • 8.3. FLOW CYTOMETRY
  • 8.4. HIGH CONTENT SCREENING
  • 8.5. LABEL FREE DETECTION

9. NORTH AMERICA CELL-BASED ASSAYS MARKET, BY APPLICATION

  • 9.1. OVERVIEW
  • 9.2. DRUG DISCOVERY
    • 9.2.1. PREDICTIVE TOXICOLOGY
    • 9.2.2. PHARMACODYNAMIC STUDIES
    • 9.2.3. ADME RESEARCH
  • 9.3. BASIC RESEARCH
  • 9.4. OTHERS

10. NORTH AMERICA CELL-BASED ASSAYS MARKET, BY END USER

  • 10.1. OVERVIEW
  • 10.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.3. CONTRACT RESEARCH ORGANIZATIONS
  • 10.4. ACADEMIC & RESEARCH INSTITUTIONS
  • 10.5. GOVERNMENT ORGANIZATIONS
  • 10.6. OTHERS

11. NORTH AMERICA CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL

  • 11.1. OVERVIEW
  • 11.2. DIRECT
  • 11.3. INDIRECT

12. NORTH AMERICA CELL BASED ASSAY MARKET, BY GEOGRAPHY

  • 12.1. NORTH AMERICA
    • 12.1.1. U.S.
    • 12.1.2. CANADA
    • 12.1.3. MEXICO

13. NORTH AMERICA CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE

  • 13.1. COMPANY SHARE ANALYSIS: NORTH AMERICA

14. NORTH AMERICA CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE

  • 14.1. COMPANY SHARE ANALYSIS: NORTH AMERICA

15. COMPANY PROFILE

  • 15.1. GENERAL ELECTRIC
    • 15.1.1. COMPANY SNAPSHOT
    • 15.1.2. REVENUE ANALYSIS
    • 15.1.3. COMPANY SHARE ANALYSIS
    • 15.1.4. PRODUCT PORTFOLIO
    • 15.1.5. RECENT DEVELOPMENTS
  • 15.2. DANAHER
    • 15.2.1. COMPANY SNAPSHOT
    • 15.2.2. REVENUE ANALYSIS
    • 15.2.3. COMPANY SHARE ANALYSIS
    • 15.2.4. PRODUCT PORTFOLIO
    • 15.2.5. RECENT DEVELOPMENT
  • 15.3. AGILENT TECHNOLOGIES, INC.
      • 15.3.1.1. COMPANY SNAPSHOT
    • 15.3.2. REVENUE ANALYSIS
    • 15.3.3. COMPANY SHARE ANALYSIS
    • 15.3.4. PRODUCT PORTFOLIO
    • 15.3.5. RECENT DEVELOPMENTS
  • 15.4. THERMO FISHER SCIENTIFIC INC
    • 15.4.1. COMPANY SNAPSHOT
    • 15.4.2. REVENUE ANALYSIS
    • 15.4.3. COMPANY SHARE ANALYSIS
    • 15.4.4. PRODUCT PORTFOLIO
    • 15.4.5. RECENT DEVELOPMENT
  • 15.5. MERCK KGAA
    • 15.5.1. COMPANY SNAPSHOT
    • 15.5.2. REVENUE ANALYSIS
    • 15.5.3. PRODUCT PORTFOLIO
    • 15.5.4. RECENT DEVELOPMENT
  • 15.6. PERKINELMER INC, INC.
    • 15.6.1. COMPANY SNAPSHOT
    • 15.6.2. REVENUE ANALYSIS
    • 15.6.3. PRODUCT PORTFOLIO
    • 15.6.4. RECENT DEVELOPMENT
  • 15.7. BIO-RAD LABORATORIES, INC.
    • 15.7.1. COMPANY SNAPSHOT
    • 15.7.2. REVENUE ANALYSIS
    • 15.7.3. PRODUCT PORTFOLIO
    • 15.7.4. RECENT DEVELOPMENTS
  • 15.8. ATCC
    • 15.8.1. COMPANY SNAPSHOT
    • 15.8.2. PRODUCT PORTFOLIO
    • 15.8.3. RECENT DEVELOPMENT
  • 15.9. AURELIA BIOSCIENCE LTD.
    • 15.9.1. COMPANY SNAPSHOT
    • 15.9.2. SERVICE PORTFOLIO
    • 15.9.3. RECENT DEVELOPMENT
  • 15.10. BD
    • 15.10.1. COMPANY SNAPSHOT
    • 15.10.2. REVENUE ANALYSIS
    • 15.10.3. PRODUCT PORTFOLIO
    • 15.10.4. RECENT DEVELOPMENTS
  • 15.11. BIOAGILYTIX LABS
    • 15.11.1. COMPANY SNAPSHOT
    • 15.11.2. SERVICE PORTFOLIO
    • 15.11.3. RECENT DEVELOPMENTS
  • 15.12. BIOVISION INC.
    • 15.12.1. COMPANY SNAPSHOT
    • 15.12.2. PRODUCT PORTFOLIO
    • 15.12.3. RECENT DEVELOPMENT
  • 15.13. CELL SIGNALING TECHNOLOGY, INC.
    • 15.13.1. COMPANY SNAPSHOT
    • 15.13.2. PRODUCT PORTFOLIO
    • 15.13.3. RECENT DEVELOPMENT
  • 15.14. CISBIO
    • 15.14.1. COMPANY SNAPSHOT
    • 15.14.2. PRODUCT PORTFOLIO
    • 15.14.3. RECENT DEVELOPMENT
  • 15.15. ENZO BIOCHEM INC.
    • 15.15.1. COMPANY SNAPSHOT
    • 15.15.2. REVENUE ANALYSIS
    • 15.15.3. PRODUCT PORTFOLIO
    • 15.15.4. RECENT DEVELOPMENT
  • 15.16. EUROFINS SCIENTIFIC
    • 15.16.1. COMPANY SNAPSHOT
    • 15.16.2. REVENUE ANALYSIS
    • 15.16.3. PRODUCT AND SERVICE PORTFOLIO
    • 15.16.4. RECENT DEVELOPMENTS
  • 15.17. LAKEPHARMA, INC.
    • 15.17.1. COMPANY SNAPSHOT
    • 15.17.2. SERVICE PORTFOLIO
    • 15.17.3. RECENT DEVELOPMENT
  • 15.18. LONZA
    • 15.18.1. COMPANY SNAPSHOT
    • 15.18.2. REVENUE ANALYSIS
    • 15.18.3. SERVICE PORTFOLIO
    • 15.18.4. RECENT DEVELOPMENT
  • 15.19. MILTENYI BIOTEC
    • 15.19.1. COMPANY SNAPSHOT
      • 15.19.2.2. PRODUCT PORTFOLIO
    • 15.19.3. RECENT DEVELOPMENT
  • 15.20. XENO DIAGNOSTICS, LLC.
    • 15.20.1. COMPANY SNAPSHOT
    • 15.20.2. PRODUCT PORTFOLIO
    • 15.20.3. RECENT DEVELOPMENT

16. QUESTIONNAIRE

17. RELATED REPORTS

LIST OF TABLES

  • TABLE 1 AGEING WORLD POPULATION (IN MILLIONS)
  • TABLE 2 TABLE REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS)
  • TABLE 3 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
  • TABLE 4 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 5 NORTH AMERICA CELL VIABILITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6 NORTH AMERICA CYTOTOXICITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 NORTH AMERICA CELL PROLIFERATION ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 NORTH AMERICA CELL DEATH ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 NORTH AMERICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 NORTH AMERICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 11 NORTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 NORTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 13 NORTH AMERICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 14 NORTH AMERICA SERVICES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 NORTH AMERICA INSTRUMENTS AND SOFTWARE IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 17 NORTH AMERICA HIGH THROUGHPUT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 NORTH AMERICA FLOW CYTOMETRY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 NORTH AMERICA HIGH CONTENT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20 NORTH AMERICA LABEL FREE DETECTION IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 NORTH AMERICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 22 NORTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23 NORTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 24 NORTH AMERICA BASIC RESEARCH IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25 NORTH AMERICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 NORTH AMERICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 27 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 28 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 30 NORTH AMERICA GOVERNMENT ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 NORTH AMERICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32 NORTH AMERICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 33 NORTH AMERICA DIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 34 NORTH AMERICA INDIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 35 NORTH AMERICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 36 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 37 NORTH AMERICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 38 NORTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 39 NORTH AMERICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 40 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 41 NORTH AMERICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 42 NORTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 43 NORTH AMERICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 44 NORTH AMERICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 45 U.S. CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 46 U.S. CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 47 U.S. CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 48 U.S. CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 49 U.S. CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 50 U.S. CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 51 U.S. DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 52 U.S. CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 53 U.S CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 54 CANADA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 55 CANADA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 56 CANADA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 57 CANADA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 58 CANADA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 59 CANADA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 60 CANADA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 61 CANADA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 62 CANADA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 63 MEXICO CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 64 MEXICO CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 65 MEXICO CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 66 MEXICO CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 67 MEXICO CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 68 MEXICO CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 69 MEXICO DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 70 MEXICO CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 71 MEXICO CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA CELL BASED ASSAYS MARKET
  • FIGURE 2 NORTH AMERICA CELL BASED ASSAYS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 NORTH AMERICA CELL BASED ASSAYS MARKET: DROC ANALYSIS
  • FIGURE 4 NORTH AMERICA CELL BASED ASSAYS MARKET: NORTH AMERICA VS REGIONAL ANALYSIS
  • FIGURE 5 NORTH AMERICA CELL BASED ASSAYS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 NORTH AMERICA CELL BASED ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 NORTH AMERICA CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 NORTH AMERICA CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID (ON THE BASIS OF SERVICES)
  • FIGURE 9 NORTH AMERICA CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF PRODUCTS)
  • FIGURE 10 NORTH AMERICA CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF SERVICES)
  • FIGURE 11 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA CELL BASED ASSAYS MARKET
  • FIGURE 12 WORLDWIDE BIOPHARMA COMPANIES R&D EXPENDITURE (IN MILLION U.S. DOLLARS)
  • FIGURE 13 NORTH AMERICA CELL BASED ASSAYS MARKET: SEGMENTATION
  • FIGURE 14 INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES ARE EXPECTED TO DRIVE THE NORTH AMERICA CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 15 CELL VIABILITY ASSAY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 16 NORTH AMERICA CELL BASED ASSAYS MARKET DOMINATED BY CELL VIABILITY ASSAY (2018)
  • FIGURE 17 NORTH AMERICA CELL BASED ASSAYS MARKET: BY TYPE, 2018
  • FIGURE 18 NORTH AMERICA CELL BASED ASSAYS MARKET: BY TYPE, CAGR (2019-2026)
  • FIGURE 19 NORTH AMERICA CELL BASED ASSAYS MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 20 NORTH AMERICA CELL BASED ASSAYS MARKET DOMINATED BY CONSUMABLES (2018)
  • FIGURE 21 NORTH AMERICA CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, 2018
  • FIGURE 22 NORTH AMERICA CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, CAGR (2019-2026)
  • FIGURE 23 NORTH AMERICA CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
  • FIGURE 24 NORTH AMERICA CELL BASED ASSAYS MARKET DOMINATED BY HIGH THROUGHPUT SCREENING (2018)
  • FIGURE 25 NORTH AMERICA CELL BASED ASSAYS MARKET: BY TECHNOLOGY, 2018
  • FIGURE 26 NORTH AMERICA CELL BASED ASSAYS MARKET: BY TECHNOLOGY, CAGR (2019-2026)
  • FIGURE 27 NORTH AMERICA CELL BASED ASSAYS MARKET: BY TECHNOLOGY, LIFELINE CURVE
  • FIGURE 28 NORTH AMERICA CELL BASED ASSAYS MARKET DOMINATED BY DRUG DISCOVERY (2018)
  • FIGURE 29 NORTH AMERICA CELL BASED ASSAYS MARKET: BY APPLICATION, 2018
  • FIGURE 30 NORTH AMERICA CELL BASED ASSAYS MARKET: BY APPLICATION, CAGR (2019-2026)
  • FIGURE 31 NORTH AMERICA CELL BASED ASSAYS MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 32 NORTH AMERICA CELL BASED ASSAYS MARKET DOMINATED BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (2018)
  • FIGURE 33 NORTH AMERICA CELL BASED ASSAYS MARKET: BY END USER, 2018
  • FIGURE 34 NORTH AMERICA CELL BASED ASSAYS MARKET: BY END USER, CAGR (2019-2026)
  • FIGURE 35 NORTH AMERICA CELL BASED ASSAYS MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 36 NORTH AMERICA CELL BASED ASSAYS MARKET DOMINATED BY DIRECT (2018)
  • FIGURE 37 NORTH AMERICA CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, 2018
  • FIGURE 38 NORTH AMERICA CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2019-2026)
  • FIGURE 39 NORTH AMERICA CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 1 NORTH AMERICA CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 2 NORTH AMERICA CELL BASED ASSAY MARKET: BY COUNTRY (2018)
  • FIGURE 3 NORTH AMERICA CELL BASED ASSAY MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 4 NORTH AMERICA CELL BASED ASSAY MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 5 NORTH AMERICA CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 6 NORTH AMERICA CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 7 NORTH AMERICA CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
Back to Top